Cardiology Today: AHA: Aggressive treatment may benefit patients with diabetes, CAD

The treatment of CAD in patients with type 2 diabetes may need to be more aggressive compared with those without diabetes to reduce the risk for MI and other complications, according to an American Heart Association scientific statement published in Circulation.

“What we’ve learned in the past decade is how you control glucose levels has a huge influence on cardiovascular risk,” said Suzanne Arnold, MD, cardiologist at Saint Luke’s Mid America Heart Institute. “Lowering blood sugars to a certain level is not sufficient. There are now more options for controlling glucose in people with type 2 diabetes, and each patient should be evaluated for their personal risk of cardiovascular disease, stroke and kidney disease. This combined health information, as well as the patient’s age, should be used to determine the appropriate therapies to lower glucose.”

Read the full Cardiology Today article: AHA: Aggressive treatment may benefit patients with diabetes, CAD

Related Content

Plaque in artery illustration
Apr. 15, 2019

Cardiovascular Business: Patients with type 2 diabetes and heart disease may require more aggressive, modern treatments
Treating coronary artery disease in patients with type 2 diabetes may require a more aggressive treatment approach than normal, according to a new scientific statement from the AHA. Cardiovascular Business highlights the findings of Dr. Suzanne Arnold and her colleagues.

Suzanne V Arnold, MD

Cardiology